Predicting peptide binding to Major Histocompatibility Complex molecules

Autoimmunity Reviews

Volumn 10, Issue 8, 2011, Pages 469-473

  Liao, Webber W P ^a   Arthur, Jonathan W ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Binding prediction; Free energy; HLA; MHC; Peptide; Structure

Indexed keywords

BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALGORITHM; ANTIGEN PRESENTATION; ARTIFICIAL INTELLIGENCE; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MAJOR HISTOCOMPATIBILITY COMPLEX; POSITION WEIGHT MATRIX; PREDICTION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; T LYMPHOCYTE;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS; COMPUTATIONAL BIOLOGY; HISTOCOMPATIBILITY ANTIGENS; HLA ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79957628239     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.02.003     Document Type: Review

References (45)

1. Saalmüller A. New understanding of immunological mechanisms. Vet Microbiol 2006, 117(1):32-38.
2. Klein J., Sato A. The HLA system: first of two parts. N Engl J Med 2000, 343(10):702-709.
3. Rioux J.D., Abbas A.K. Paths to understanding the genetic basis of autoimmune disease. Nature 2005, 435(7042):584-589.
4. Wang D.Q., Hill J.A., Cairns E., Bell D.A. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice. J Autoimmun 2002, 18(2):95-103.
5. de Vries R.R.P., Huizinga T.W.J., Toes R.E.M. Redefining the HLA and RA association: to be or not to be anti-CCP positive. J Autoimmun 2005, 25:21-25.
6. Fernández-Morera J.L., Calvanese V., Rodríguez-Rodero S., Menéndez-Torre E., Fraga M.F. Epigenetic regulation of the immune system in health and disease. Tissue Antigens 2010, 76(6):431-439.
7. Plot L., Amital H. Infectious associations of Celiac disease. Autoimmun Rev 2009, 8(4):316-319.
8. Bach J.-F. Infections and autoimmune diseases. J Autoimmun 2005, 25:74-80.
9. Dieudé P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev 2010, epub ahead of print.
10. Oliveira L.C., Porta G., Marin M.L.C., Bittencourt P.L., Kalil J., Goldberg A.C. Autoimmune Hepatitis, HLA and extended haplotypes. Autoimmun Rev 2010, epub ahead of print.
11. Rudensky A., Janeway C.A. Studies on naturally processed peptides associated with MHC class II molecules. Chem Immunol 1993, 57:134-151.
12. Godkin A.J., Smith K.J., Willis A., Tejada-Simon M.V., Zhang J., Elliott T., et al. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol 2001, 166(11):6720-6727.
13. Rothbard J.B., Taylor W.R. A sequence pattern common to T cell epitopes. EMBO J 1988, 7(1):93-100.
14. Udaka K., Wiesmüller K.-H., Kienle S., Jung G., Tamamura H., Yamagishi H., et al. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 2000, 51(10):816-828.
15. Doytchinova I.A., Blythe M.J., Flower D.R. Additive method for the prediction of protein-peptide binding affinity. application to the MHC class I molecule HLA-A 0201. J Proteome Res 2002, 1(3):263-272.
16. Peters B., Tong W., Sidney J., Sette A., Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 2003, 19(14):1765-1772.
17. Peters B., Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinform 2005, 6:132.
18. Nielsen M., Lundegaard C., Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinform 2007, 8:238.
19. Sidney J., Assarsson E., Moore C., Ngo S., Pinilla C., Sette A., et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 2008, 4:2.
20. Buus S., Lauemøller S.L., Worning P., Kesmir C., Frimurer T., Corbet S., et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003, 62(5):378-384.
21. Nielsen M., Lundegaard C., Worning P., Lauemøller S.L., Lamberth K., Buus S., et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003, 12(5):1007-1017.
22. Noguchi H., Kato R., Hanai T., Matsubara Y., Honda H., Brusic V., et al. Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J Biosci Bioeng 2002, 94(3):264-270.
23. Nielsen M., Lundegaard C., Worning P., Sylvester-Hvid C., Lamberth K., Buus S., et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 2004, 20(9):1388-1397.
24. Dönnes P., Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res 2006, 34:W194-W197. Web Server issue.
25. Liu W., Meng X., Xu Q., Flower D.R., Li T. Quantitative prediction of mouse class I MHC peptide binding affinity support vector machine regression (SVR) models. BMC Bioinform 2006, 7:182.
26. Murugan N., Dai Y. Prediction of MHC class II binding peptides based on an iterative learning model. Immunome Res 2005, 1:6.
27. Zhang W., Liu J., Niu Y.Q., Wang L., Hu X. A Bayesian regression approach to the prediction of MHC-II binding affinity. Comput Meth Programs Biomed 2008, 92(1):1-7.
28. Nielsen M., Lundegaard C., Blicher T., Lamberth K., Harndahl M., Justesen S., et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2007, 2(8):e796.
29. Nielsen M., Lundegaard C., Blicher T., Peters B., Sette A., Justesen S., et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008, 4(7):e1000107.
30. Hoof I., Peters B., Sidney J., Pedersen L.E., Sette A., Lund O., et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009, 61(1):1-13.
31. Schueler-Furman O., Altuvia Y., Sette A., Margalit H. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci 2000, 9(9):1838-1846.
32. Altuvia Y., Margalit H. A structure-based approach for prediction of MHC-binding peptides. Methods 2004, 34(4):454-459.
33. Kumar N., Mohanty D. MODPROPEP: a program for knowledge-based modeling of protein-peptide complexes. Nucleic Acids Res 2007, 35(suppl. 2):W549-W555.
34. Logean A., Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. J Comput Aided Mol Des 2002, 16(4):229-243.
35. Bui H.-H., Schiewe A.J., von Grafenstein H., Haworth I.S. Structural prediction of peptides binding to MHC class I molecules. Proteins 2006, 63(1):43-52.
36. Doytchinova I.A., Flower D.R. Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A 0201. J Med Chem 2001, 44(22):3572-3581.
37. Doytchinova I.A., Guan P., Flower D.R. Quantitative structure-activity relationships and the prediction of MHC supermotifs. Methods 2004, 34(4):444-453.
38. Hattotuwagama C.K., Doytchinova I.A., Flower D.R. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Meth Mol Biol 2007, 409:227-245.
39. Li Z., Wu S., Chen Z., Ye N., Yang S., Liao C., et al. Structural parameterization and functional prediction of antigenic polypeptome sequences with biological activity through quantitative sequence-activity models (QSAM) by molecular electronegativity edge-distance vector (VMED). Sci China C Life Sci 2007, 50(5):706-716.
40. Doytchinova I.A., Flower D.R. Physicochemical explanation of peptide binding to HLA-A0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study. Proteins 2002, 48(3):505-518.
41. Doytchinova I.A., Flower D.R. A Comparative Molecular Similarity Index Analysis (CoMSIA) study identifies an HLA-A2 binding supermotif. J Comput Aided Mol Des 2002, 16(8):535-544.
42. Miyazawa S., Jernigan R.L. Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading. J Mol Biol 1996, 256(3):623-644.
43. Betancourt M.R., Thirumalai D. Pair potentials for protein folding: choice of reference states and sensitivity of predicted native states to variations in the interaction schemes. Protein Sci 1999, 8(2):361-369.
44. Jojic N., Reyes-Gomez M., Heckerman D., Kadie C., Schueler-Furman O. Learning MHC I-peptide binding. Bioinformatics 2006, 22(14):e227-e235.
45. Zhang H., Wang P., Papangelopoulos N., Xu Y., Sette A., Bourne P.E., et al. Limitations of ab initio predictions of peptide binding to MHC class II molecules. PLoS ONE 2010, 5(2):e9272.